← Back to news

Markets

My Top Dividend Stock to Buy in July and Hold Forever

Y

Here’s Why Nvidia Might Be the New Value Play in Semiconductors

Y

Is Genmab A/S (GMAB) Stock Undervalued After Positive Epkinly DLBCL Trial Results?

Y

Is Crinetics Pharmaceuticals, Inc. (CRNX) Stock a Buying Opportunity After a 44% Pullback?

Y

Record Money Is Pouring Into Emerging Markets. This One Difference Could Decide Your Returns

Y

The Hour-Long Project We Never Would’ve Started

Y

Three Most Valuable Companies at $13 Trillion: Buy, Sell, or Hold

Y

Solo GP Ashley Smith announces second $25M fund to back startups in AI, security and more

Y

23andMe data breach settlement of $46.75 million approved

Y

Tech CEOs Ditch the AI Jobs Apocalypse Narrative

Y

AI confidence is on the rise despite cost concerns

Y

Interview: Citi’s Andrew James on private markets, portfolio resilience and long-term wealth creation

Y

Air Canada Picks Outsider as Next CEO to Rebuild Trust After Video Fallout

Y

Bank of America Says Clients Were Finally Buying Stocks Last Week

Y

UTM seals gas sales pact with Seplat and NNPC for Yoho FLNG project

Y

Micron Earnings: I Was Worried For Nothing (Rating Upgrade)

S

Is TransMedics Group, Inc. (TMDX) Stock Still a MedTech Growth Opportunity After Analyst Target Cut?

Y

Can Alcon Inc. (ALC) Stock Rebound as New Eye Care Products Approach Regulatory Milestones?

Y

Is Insulet Corporation (PODD) Stock Still a Diabetes Device Growth Opportunity After Analyst Target Cut?

Y

Is Ionis Pharmaceuticals, Inc. (IONS) Stock a Buy After Tryngolza’s FDA Approval?

Y

Is Agilent Technologies, Inc. (A) Stock Positioned for Growth as Life Sciences Sector Trends Stabilize?

Y

Is United Therapeutics Corporation (UTHR) Stock a Long-Term Opportunity in Organ Transplant Innovation?

Y

Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut?

Y

Want Anthropic Exposure Before the IPO? These 2 AI Giants Are Already There

Y

2 Great Developments for Ford but Not for Rivian and Lucid

Y

Is Abbott Laboratories (ABT) Stock Still a Healthcare Growth Opportunity After Analyst Target Cut?

Y

Here’s What Analysts Say About Advanced Micro Devices, Inc. (AMD)

Y

Is Varonis Systems, Inc. (VRNS) among the Best Cybersecurity Stocks to Buy and Hold for the Long Term?

Y

Here is why Palantir Technologies Inc. (PLTR) is among the 12 Best Cybersecurity Stocks to Buy and Hold for the Long Term

Y

Stocks, bonds retreat after Trump says Iran MOU 'is over'

Y

SentinelOne (S) Unveils AI That Can Investigate Cyber Threats Without Human Help

Y

Backblaze (BLZE) Lands $335 Million AI Infrastructure Deal

Y

Calix (CALX) Scores New AI Platform Customer to Drive Growth

Y

Nayax (NYAX) Earns Higher Price Target as Growth Story Builds

Y

Cloudflare (NET) Launches New Partner Program to Speed AI Security Adoption

Y

Google vs. Microsoft: The AI Economics War Has a Clear Winner (and a Clear Buy)

Y

Grant Thornton Picks CrowdStrike (CRWD) to Power Its Global Cybersecurity Platform

Y

Samsara (IOT) Continues to Win Wall Street’s Confidence

Y

Bandwidth (BAND) Unveils $275 Million Financing Plan—Here’s Why It Matters

Y

Why Zeta Global’s (ZETA) New AI Alliance Has Wall Street Paying Attention

Y

Wife, 35, Found Four Secret Credit Cards In Her Husband's Name Totaling $45,000 — He'd Been Hiding Them In A PO Box For Three Years

Y

Price Prediction: Can Costco Stock Double by 2032?

Y

Shell forecasts upgraded as brokers account for the incremental positives

Y

What to Expect From Mettler-Toledo's Next Quarterly Earnings Report

Y

Will Financial Markets Crash in July? Iran Ceasefire Collapse Puts Investors to the Test

Y

Strategy Just Broke Its Biggest Bitcoin Rule. What It Means for MSTR Stock.

Y

Dollar Climbs on Escalation of Middle East Hostilities

Y

Great Southern completes first RC drilling at Especularita project

Y

JPMorgan, big banks seek to unlock value in struggling payments stock

Y

What Betting Markets Really Think About the Stripe, Discord, and Anduril IPOs

Y